|
|
|
Insider
Information: |
Domzalski David |
Relationship: |
|
City: |
Rehovot |
State: |
L3 |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
494,160 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$110,445 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
494,160 |
|
|
Total
Value |
$110,445 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
Percentage
Gain/Loss : |
-26.3%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Foamix Pharmaceuticals Ltd |
FOMX |
CEO, Director |
2020-03-09 |
0 |
2018-01-01 |
0 |
Premium* |
|
VYNE Therapeutics Inc |
VYNE |
|
2024-04-01 |
494,160 |
2020-03-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
55 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
FOMX |
Foamix Pharmaceuticals Lt... |
CEO |
|
2018-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,948 |
142,819 |
0 |
- |
|
FOMX |
Foamix Pharmaceuticals Lt... |
CEO |
|
2018-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
23,396 |
163,150 |
0 |
- |
|
FOMX |
Foamix Pharmaceuticals Lt... |
CEO |
|
2019-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
73,282 |
219,691 |
0 |
- |
|
FOMX |
Foamix Pharmaceuticals Lt... |
CEO |
|
2020-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
103,248 |
319,323 |
0 |
- |
|
FOMX |
Foamix Pharmaceuticals Lt... |
CEO |
|
2020-03-09 |
4 |
D |
$0.00 |
$0 |
D/D |
(324,028) |
0 |
0 |
- |
|
VYNE |
VYNE Therapeutics Inc |
President and CEO |
|
2020-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
191,952 |
191,952 |
0 |
- |
|
VYNE |
VYNE Therapeutics Inc |
President and CEO |
|
2020-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
391,489 |
578,985 |
0 |
- |
|
VYNE |
VYNE Therapeutics Inc |
President and CEO |
|
2020-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
680,000 |
1,247,213 |
0 |
- |
|
VYNE |
VYNE Therapeutics Inc |
President and CEO |
|
2021-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
153,750 |
479,833 |
0 |
- |
|
VYNE |
VYNE Therapeutics Inc |
President and CEO |
|
2021-09-02 |
4 |
A |
$0.00 |
$0 |
D/D |
320,312 |
775,911 |
0 |
- |
|
VYNE |
VYNE Therapeutics Inc |
President and CEO |
|
2022-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
312,302 |
1,072,935 |
0 |
- |
|
VYNE |
VYNE Therapeutics Inc |
President and CEO |
|
2023-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
225,000 |
271,168 |
0 |
- |
|
VYNE |
VYNE Therapeutics Inc |
President and CEO |
|
2024-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
225,000 |
496,168 |
0 |
- |
|
VYNE |
VYNE Therapeutics Inc |
President and CEO |
|
2022-12-31 |
4 |
D |
$0.15 |
$1,603 |
D/D |
(10,685) |
1,064,290 |
0 |
- |
|
VYNE |
VYNE Therapeutics Inc |
President and CEO |
|
2022-11-30 |
4 |
A |
$0.20 |
$6,861 |
D/D |
34,705 |
1,074,975 |
0 |
- |
|
VYNE |
VYNE Therapeutics Inc |
President and CEO |
|
2022-09-30 |
4 |
D |
$0.22 |
$2,382 |
D/D |
(10,683) |
1,040,270 |
0 |
- |
|
VYNE |
VYNE Therapeutics Inc |
President and CEO |
|
2022-05-31 |
4 |
A |
$0.35 |
$4,116 |
D/D |
11,887 |
1,061,636 |
0 |
- |
|
VYNE |
VYNE Therapeutics Inc |
President and CEO |
|
2022-06-30 |
4 |
D |
$0.39 |
$4,156 |
D/D |
(10,683) |
1,050,953 |
0 |
- |
|
VYNE |
VYNE Therapeutics Inc |
President and CEO |
|
2022-03-31 |
4 |
D |
$0.65 |
$15,071 |
D/D |
(23,186) |
1,049,749 |
0 |
- |
|
VYNE |
VYNE Therapeutics Inc |
President and CEO |
|
2021-11-30 |
4 |
A |
$0.88 |
$4,119 |
D/D |
4,705 |
767,520 |
0 |
- |
|
VYNE |
VYNE Therapeutics Inc |
President and CEO |
|
2021-12-31 |
4 |
D |
$1.02 |
$7,025 |
D/D |
(6,887) |
760,633 |
0 |
- |
|
VYNE |
VYNE Therapeutics Inc |
President and CEO |
|
2020-09-08 |
4 |
B |
$1.38 |
$103,568 |
D/D |
75,000 |
1,315,966 |
2.81 |
% |
|
VYNE |
VYNE Therapeutics Inc |
President and CEO |
|
2021-09-30 |
4 |
D |
$1.39 |
$18,203 |
D/D |
(13,096) |
762,815 |
0 |
- |
|
VYNE |
VYNE Therapeutics Inc |
President and CEO |
|
2020-04-06 |
4 |
D |
$1.40 |
$16,481 |
D/D |
(11,772) |
567,213 |
0 |
- |
|
VYNE |
VYNE Therapeutics Inc |
President and CEO |
|
2020-11-30 |
4 |
A |
$1.45 |
$6,160 |
D/D |
4,263 |
1,313,990 |
0 |
- |
|
55 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|